133 related articles for article (PubMed ID: 37619265)
41. Self-assembled nanoparticles comprising aptide-SN38 conjugates for use in targeted cancer therapy.
Kim H; Lee Y; Kang S; Choi M; Lee S; Kim S; Gujrati V; Kim J; Jon S
Nanotechnology; 2016 Dec; 27(48):48LT01. PubMed ID: 27804918
[TBL] [Abstract][Full Text] [Related]
42. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
[TBL] [Abstract][Full Text] [Related]
43. Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and Biocompatibility.
Satomaa T; Pynnönen H; Vilkman A; Kotiranta T; Pitkänen V; Heiskanen A; Herpers B; Price LS; Helin J; Saarinen J
Antibodies (Basel); 2018 Mar; 7(2):. PubMed ID: 31544867
[TBL] [Abstract][Full Text] [Related]
44. CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates.
Govindan SV; Cardillo TM; Moon SJ; Hansen HJ; Goldenberg DM
Clin Cancer Res; 2009 Oct; 15(19):6052-61. PubMed ID: 19789330
[TBL] [Abstract][Full Text] [Related]
45. Determination of drug-to-antibody ratio of antibody-drug conjugate in biological samples using microflow-liquid chromatography/high-resolution mass spectrometry.
Inoue K; Mochizuki T; Kasamori N; Komori T
Bioanalysis; 2022 Dec; 14(24):1533-1545. PubMed ID: 36825963
[TBL] [Abstract][Full Text] [Related]
46. TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy.
Hegedüs L; Okumus Ö; Mairinger F; Ploenes T; Reuter S; Schuler M; Welt A; Vega-Rubin-de-Celis S; Theegarten D; Bankfalvi A; Aigner C; Hegedüs B
Lung Cancer; 2023 Apr; 178():237-246. PubMed ID: 36907051
[TBL] [Abstract][Full Text] [Related]
47. General and Robust Chemoenzymatic Method for Glycan-Mediated Site-Specific Labeling and Conjugation of Antibodies: Facile Synthesis of Homogeneous Antibody-Drug Conjugates.
Zhang X; Ou C; Liu H; Prabhu SK; Li C; Yang Q; Wang LX
ACS Chem Biol; 2021 Nov; 16(11):2502-2514. PubMed ID: 34569782
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy.
Tong XM; Feng L; Suthe SR; Weng TH; Hu CY; Liu YZ; Wu ZG; Wang MH; Yao HP
J Immunother Cancer; 2019 Sep; 7(1):250. PubMed ID: 31519211
[TBL] [Abstract][Full Text] [Related]
49. Cholesterol-Inulin Conjugates for Efficient SN38 Nuclear Delivery: Nanomedicines for Precision Cancer Therapy.
Mauro N; Utzeri MA; Cillari R; Scialabba C; Giammona G; Cavallaro G
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230779
[TBL] [Abstract][Full Text] [Related]
50. Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates.
Tedeschini T; Campara B; Grigoletto A; Bellini M; Salvalaio M; Matsuno Y; Suzuki A; Yoshioka H; Pasut G
J Control Release; 2021 Sep; 337():431-447. PubMed ID: 34329685
[TBL] [Abstract][Full Text] [Related]
51. Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody-Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer.
Gregson SJ; Pugh K; Patel N; Afif-Rider S; Vijayakrishnan B; Santos K; Riedl J; Hutchinson I; Kang GD; Chooi KP; Beard R; Adams L; Barry CS; Ball K; Masterson LA; McFarlane M; Hartley JA; Howard PW
Mol Cancer Ther; 2022 Sep; 21(9):1439-1448. PubMed ID: 35793464
[TBL] [Abstract][Full Text] [Related]
52. In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy.
Zhao J; Ma S; Xu Y; Si X; Yao H; Huang Z; Zhang Y; Yu H; Tang Z; Song W; Chen X
Biomaterials; 2021 Jan; 268():120542. PubMed ID: 33249316
[TBL] [Abstract][Full Text] [Related]
53. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
54. A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer.
Huhe M; Lou J; Zhu Y; Zhao Y; Shi Y; Wang B; Sun X; Zhang X; Zhang Y; Chen ZN
Biochem Biophys Res Commun; 2019 Jun; 513(4):1083-1091. PubMed ID: 31010682
[TBL] [Abstract][Full Text] [Related]
55. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
Liu XY; Zhen YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
[TBL] [Abstract][Full Text] [Related]
56. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.
Marcoux J; Champion T; Colas O; Wagner-Rousset E; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Protein Sci; 2015 Aug; 24(8):1210-23. PubMed ID: 25694334
[TBL] [Abstract][Full Text] [Related]
57. Hiding Payload Inside the IgG Fc Cavity Significantly Enhances the Therapeutic Index of Antibody-Drug Conjugates.
Shi W; Zhang J; Liu L; Li W; Liu Z; Ren A; Wang J; Tang C; Yang Y; Xu D; Huang Q; Wang Y; Luo C; Huang W; Tang F
J Med Chem; 2023 Jan; 66(1):1011-1026. PubMed ID: 36584232
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and evaluation of highly releasable and structurally stable antibody-SN-38-conjugates.
Liu L; Xie F; Xiao D; Xu X; Su Z; Wang Y; Fan S; Zhou X; Li S
Drug Deliv; 2021 Dec; 28(1):2603-2617. PubMed ID: 34894942
[TBL] [Abstract][Full Text] [Related]
59. Transglutaminase-Mediated Conjugations.
Anami Y; Tsuchikama K
Methods Mol Biol; 2020; 2078():71-82. PubMed ID: 31643050
[TBL] [Abstract][Full Text] [Related]
60. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs).
Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W
J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]